IDEX Corporation

IEX Industrials Specialty Industrial Machinery

IDEX Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.5 billion, up 5.77% from fiscal 2024.

Revenue
+8.31%
EPS
+14.9%
Free cash flow
+13.6%
Total debt
−7.93%

Quarter to September 2026, against a year earlier

222.34 11.35 −4.86%
Market cap
$16.4B
P/E
30.8×
Fwd P/E
31.3×
Dividend yield
1.30%
F-score
7/9
Altman Z
4.70
Beneish M
−2.51
Dividend safety
91/100

IDEX Corporation (IEX) Earnings & Analysis

Updated · Covers results through Q3 FY2026 · Earnings call · How this is made

Latest quarter

IDEX reported third-quarter revenue of $951.7 million, above the $919.4 million consensus and up from $878.7 million a year earlier. Adjusted EPS of $2.33 also exceeded the $2.23 consensus; reported diluted EPS rose to $1.95 from $1.70.

The company’s filing attributed organic sales growth to higher volumes, primarily in Health & Science Technologies (HST), and positive pricing across all segments. CFO Sean Gillen said HST organic sales grew 13%, while Fluid & Metering Technologies (FMT) grew 4% and Fire & Safety/Diversified Products (FSDP) grew 6%.

IDEX reported gross margin of 45.1%, compared with 44.5% a year earlier, and operating margin of 21.9%, compared with 21.1%. The filing said productivity, volume leverage and mix benefited gross margin, although costs were not fully recovered at historical margin rates. Free cash flow rose to $214.3 million from $188.7 million.

Gillen said organic revenue growth of 8% exceeded the company’s 5% to 7% quarterly guidance. He also said adjusted EPS and adjusted EBITDA margin exceeded their guidance ranges.

Q3 FY2026 Q3 FY2025 Change
Revenue $951.7 million $878.7 million 8.31%
Diluted EPS $1.95 $1.70 14.5%
Gross margin 45.1% 44.5% 0.7 percentage points
Operating margin 21.9% 21.1% 0.7 percentage points
Free cash flow $214.3 million $188.7 million 13.6%
Against the consensus Reported Consensus Result
Adjusted EPS $2.33 $2.23 Beat by 4.48%
Revenue $951.7 million $919.4 million Beat by 3.52%

Adjusted EPS is the figure the consensus estimates, not the GAAP EPS above.

Against its own guidance For Guided Reported Result
Revenue growth Q3 FY2026 5.00%–7.00% 8.31% Above the guide

What management said on the call

CEO Eric Ashleman said data centers, semiconductors, space and defense, and water were leading growth. He said IDEX supplies thermal-management and liquid-cooling components for data centers, while semiconductor demand spans filtration, sealing, optics and thermal management. In FMT, he said demand was broadening across industrial businesses, with signs of stabilization in agriculture and energy.

Gillen said orders grew organically across all three segments, although they declined sequentially from the second quarter, primarily because of the timing of data-center orders. Asked about order flow, Ashleman said IDEX had backlog to fulfill and described large data-center orders as “a little lumpy, a little unpredictable.” He said preseason agriculture ordering had improved, while chemicals continued to be affected by elevated input prices.

On the competitive approach, Ashleman said IDEX adapts component technologies to new applications and connects teams across acquired businesses. He cited Muon’s use of electroforming, previously deployed in respiratory applications, for fiber alignment in data centers. At Mott, he said IDEX shifted resources toward semiconductor and space and defense applications. Gillen said the acquisition contributed through mix and early continuous-improvement work.

Ashleman said inflation and energy prices continued to push input costs higher, but pricing exceeded costs in dollar terms during the quarter. Gillen said pricing contributed around 2% of revenue in the quarter and that IDEX continued to expect to price above costs.

For the fourth quarter, Gillen expects margins to decline sequentially, citing fewer production days and planned maintenance shutdowns. He said IDEX was investing capital to support growth and pursuing acquisitions that fit its existing platforms. Asked about acquisitions, Ashleman said the company was pursuing discussions but would remain disciplined about larger opportunities.

Guidance

IDEX raised its FY2026 organic growth outlook to 6.5% to 6.8% from 5% to 6%, and its adjusted EPS range to $8.91 to $8.96 from $8.70 to $8.85. Gillen said the company tightened its adjusted EBITDA margin expectation to 27.1% to 27.3%, from its prior 27.0% to 27.3% range.

Metric For Guide Previous guide Change
Revenue, Data Center Semiconductor Space and Defense FY2027 IDEX expects its data center, semiconductor, and space and defense growth drivers to remain additive in FY2027. — —
Revenue, Life Sciences FY2027 IDEX expects its life sciences business to contribute to growth in FY2027. — —
Revenue growth, Pricing FY2026 2.00% — New
EBITDA, Non Gaap Margin Q4 FY2026 IDEX expects its margins to decline sequentially in Q4 FY2026. — —
Share repurchases Q4 FY2026 $75.0 million — New
Free cash flow growth, Conversion FY2026 100.0% — New
Capex FY2026 $110.0 million $110.0 million Held
EPS, non-GAAP FY2026 $8.91–$8.96 $8.70–$8.85 Raised
EBITDA growth, Non Gaap Margin FY2026 27.1%–27.3% — New
Revenue growth, Organic FY2026 6.50%–6.80% 5.00%–6.00% Raised
EPS FY2026 $8.70–$8.85 — New
EBITDA growth FY2026 27.0%–27.3% — New
Revenue growth FY2026 5.00%–6.00% — New